Last update 21 Nov 2024

Vofatamab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
ANTI FGR3, Vofatamab (USAN)
+ [4]
Target
Mechanism
FGFR3 antagonists(Fibroblast growth factor receptor 3 antagonists)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D11445--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Urothelial CarcinomaPhase 2
IT
01 Jun 2015
Urinary Bladder DiseasesPhase 2
GB
01 Jun 2015
Urinary Bladder DiseasesPhase 2
US
01 Jun 2015
Urinary Bladder DiseasesPhase 2
TW
01 Jun 2015
Urinary Bladder DiseasesPhase 2
TR
01 Jun 2015
Urinary Bladder DiseasesPhase 2
ES
01 Jun 2015
Urinary Bladder DiseasesPhase 2
KR
01 Jun 2015
Urinary Bladder DiseasesPhase 2
IT
01 Jun 2015
Urinary Bladder DiseasesPhase 2
SE
01 Jun 2015
Urinary Bladder DiseasesPhase 2
CZ
01 Jun 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
28
pdmgebyebf(kfotmewdat) = aqcrwqasij pfjqzhosyp (nlcvdndwhv, ylzswjizhd - klqyvrzglg)
-
18 Mar 2020
Phase 1/2
71
(Vofatamab Plus Docetaxel)
neklcwzpqv(msfqqwwfps) = phqwvyxucm egpgcisdoz (wpfobawmvg, idlhcpcexh - lmrdyqkamk)
-
17 Feb 2020
(Vofatamab)
neklcwzpqv(msfqqwwfps) = ibgpxrklfz egpgcisdoz (wpfobawmvg, nuuukclblr - jvnfeoivix)
Phase 1/2
28
(eeymdzshmy) = zzfjqfwvts uldrclecbo (iibpewpjwj )
-
30 Sep 2019
Phase 1/2
35
(cgfgqgevgo) = Not reached cikvavqqpi (trxbfvsstf )
Positive
03 Jun 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free